Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 118

1.

Racial Disparities in the Receipt of Guideline Care and Cancer Deaths for Women with Ovarian Cancer.

Cronin KA, Howlader N, Stevens JL, Trimble EL, Harlan LC, Warren JL.

Cancer Epidemiol Biomarkers Prev. 2019 Mar;28(3):539-545. doi: 10.1158/1055-9965.EPI-18-0285. Epub 2018 Nov 28.

PMID:
30487136
2.

Treatment and Survival Disparities in the National Cancer Institute's Patterns of Care Study (1987-2017).

Penn DC, Baker M, Geiger AM, Harlan LC.

Cancer Invest. 2018;36(6):319-329. doi: 10.1080/07357907.2018.1474894. Epub 2018 Aug 23.

3.

Black/white differences in treatment and survival among women with stage IIIB-IV breast cancer at diagnosis: a US population-based study.

Enewold L, Penn DC, Stevens JL, Harlan LC.

Cancer Causes Control. 2018 Jul;29(7):657-665. doi: 10.1007/s10552-018-1045-9. Epub 2018 Jun 2.

PMID:
29860614
4.

Adoption of Sorafenib for the Treatment of Advanced-Stage Hepatocellular Carcinoma in Oncology Practices in the United States.

Parsons HM, Chu Q, Karlitz JJ, Stevens JL, Harlan LC.

Liver Cancer. 2017 Jun;6(3):216-226. doi: 10.1159/000473862. Epub 2017 Apr 28.

5.

Treatment and survival of childhood neuroblastoma: Evidence from a population-based study in the United States.

Coughlan D, Gianferante M, Lynch CF, Stevens JL, Harlan LC.

Pediatr Hematol Oncol. 2017 Aug;34(5):320-330. doi: 10.1080/08880018.2017.1373315. Epub 2017 Oct 17.

6.

Metastatic Melanoma: Treatment and Survival in the US after the Introduction of Ipilimumab and Vemurafenib.

Enewold L, Sharon E, Harlan LC.

Oncol Res Treat. 2017;40(4):174-183. doi: 10.1159/000456014. Epub 2017 Mar 9.

7.

Trends in the receipt of guideline care and survival for women with ovarian cancer: A population-based study.

Warren JL, Harlan LC, Trimble EL, Stevens J, Grimes M, Cronin KA.

Gynecol Oncol. 2017 Jun;145(3):486-492. doi: 10.1016/j.ygyno.2017.03.016. Epub 2017 Mar 31.

8.

Temporal patterns of care and outcomes of non-small cell lung cancer patients in the United States diagnosed in 1996, 2005, and 2010.

Kaniski F, Enewold L, Thomas A, Malik S, Stevens JL, Harlan LC.

Lung Cancer. 2017 Jan;103:66-74. doi: 10.1016/j.lungcan.2016.11.020. Epub 2016 Nov 29.

9.

Knowledge of Clinical Trial Availability and Reasons for Nonparticipation Among Adolescent and Young Adult Cancer Patients: A Population-based Study.

Shnorhavorian M, Doody DR, Chen VW, Hamilton AS, Kato I, Cress RD, West M, Wu XC, Keegan THM, Harlan LC, Schwartz SM; AYA HOPE Study Collaborative Group.

Am J Clin Oncol. 2018 Jun;41(6):581-587. doi: 10.1097/COC.0000000000000327.

PMID:
27635619
10.

Toward greater adoption of minimally invasive and nephron-sparing surgical techniques for renal cell cancer in the United States.

Banegas MP, Harlan LC, Mann B, Yabroff KR.

Urol Oncol. 2016 Oct;34(10):433.e9-433.e17. doi: 10.1016/j.urolonc.2016.05.021. Epub 2016 Jun 16.

11.

Incidence and incidence trends of the most frequent cancers in adolescent and young adult Americans, including "nonmalignant/noninvasive" tumors.

Barr RD, Ries LA, Lewis DR, Harlan LC, Keegan TH, Pollock BH, Bleyer WA; US National Cancer Institute Science of Adolescent and Young Adult Oncology Epidemiology Working Group.

Cancer. 2016 Apr 1;122(7):1000-8. doi: 10.1002/cncr.29867. Epub 2016 Feb 5.

12.

Geographic disparities in late stage breast cancer incidence: results from eight states in the United States.

Tatalovich Z, Zhu L, Rolin A, Lewis DR, Harlan LC, Winn DM.

Int J Health Geogr. 2015 Oct 24;14:31. doi: 10.1186/s12942-015-0025-5.

13.

Who Treats Adolescents and Young Adults with Cancer? A Report from the AYA HOPE Study.

Parsons HM, Harlan LC, Schmidt S, Keegan TH, Lynch CF, Kent EE, Wu XC, Schwartz SM, Chu RL, Keel G, Smith AW; AYA HOPE Collaborative Group.

J Adolesc Young Adult Oncol. 2015 Sep;4(3):141-50. doi: 10.1089/jayao.2014.0041.

14.

Impact of the AYA HOPE Comorbidity Index on Assessing Health Care Service Needs and Health Status among Adolescents and Young Adults with Cancer.

Wu XC, Prasad PK, Landry I, Harlan LC, Parsons HM, Lynch CF, Smith AW, Hamilton AS, Keegan TH; AYA HOPE Study Collaborative Group.

Cancer Epidemiol Biomarkers Prev. 2015 Dec;24(12):1844-9. doi: 10.1158/1055-9965.EPI-15-0401. Epub 2015 Sep 29.

15.

Fertility preservation knowledge, counseling, and actions among adolescent and young adult patients with cancer: A population-based study.

Shnorhavorian M, Harlan LC, Smith AW, Keegan TH, Lynch CF, Prasad PK, Cress RD, Wu XC, Hamilton AS, Parsons HM, Keel G, Charlesworth SE, Schwartz SM; AYA HOPE Study Collaborative Group.

Cancer. 2015 Oct 1;121(19):3499-506. doi: 10.1002/cncr.29328. Epub 2015 Jul 27.

16.

Patterns of Colorectal Cancer Care in the United States: 1990-2010.

Murphy CC, Harlan LC, Lund JL, Lynch CF, Geiger AM.

J Natl Cancer Inst. 2015 Jul 23;107(10). pii: djv198. doi: 10.1093/jnci/djv198. Print 2015 Oct.

17.

Race and Insurance Differences in the Receipt of Adjuvant Chemotherapy Among Patients With Stage III Colon Cancer.

Murphy CC, Harlan LC, Warren JL, Geiger AM.

J Clin Oncol. 2015 Aug 10;33(23):2530-6. doi: 10.1200/JCO.2015.61.3026. Epub 2015 Jul 6.

18.

Treatment of hepatocellular carcinoma in the community: disparities in standard therapy.

Harlan LC, Parsons HM, Wiggins CL, Stevens JL, Patt YZ.

Liver Cancer. 2015 Mar;4(1):70-83. doi: 10.1159/000367729.

19.

Gastrointestinal stromal tumors: treatment patterns of a population-based sample.

Harlan LC, Eisenstein J, Russell MC, Stevens JL, Cardona K.

J Surg Oncol. 2015 May;111(6):702-7. doi: 10.1002/jso.23879.

PMID:
25900896
20.

Oncotype Dx assay and breast cancer in the United States: usage and concordance with chemotherapy.

Enewold L, Geiger AM, Zujewski J, Harlan LC.

Breast Cancer Res Treat. 2015 May;151(1):149-56. doi: 10.1007/s10549-015-3366-7. Epub 2015 Apr 10.

PMID:
25859924
21.

Receipt of chemotherapy among medicare patients with cancer by type of supplemental insurance.

Warren JL, Butler EN, Stevens J, Lathan CS, Noone AM, Ward KC, Harlan LC.

J Clin Oncol. 2015 Feb 1;33(4):312-8. doi: 10.1200/JCO.2014.55.3107. Epub 2014 Dec 22.

22.

Global survival patterns: potential for cancer control.

Harlan LC, Warren JL.

Lancet. 2015 Mar 14;385(9972):926-8. doi: 10.1016/S0140-6736(14)62251-0. Epub 2014 Nov 26. No abstract available.

23.

Pancreatic cancer in the USA: persistence of undertreatment and poor outcome.

Enewold L, Harlan LC, Tucker T, McKenzie S.

J Gastrointest Cancer. 2015 Mar;46(1):9-20. doi: 10.1007/s12029-014-9668-x.

PMID:
25403828
24.

Thyroid cancer presentation and treatment in the United States.

Enewold L, Harlan LC, Stevens JL, Sharon E.

Ann Surg Oncol. 2015;22(6):1789-97. doi: 10.1245/s10434-014-4209-1. Epub 2014 Nov 1.

25.

Use of appropriate initial treatment among adolescents and young adults with cancer.

Potosky AL, Harlan LC, Albritton K, Cress RD, Friedman DL, Hamilton AS, Kato I, Keegan TH, Keel G, Schwartz SM, Seibel NL, Shnorhavorian M, West MM, Wu XC; AYA HOPE Study Collaborative Group.

J Natl Cancer Inst. 2014 Oct 9;106(11). pii: dju300. doi: 10.1093/jnci/dju300. Print 2014 Nov.

26.

Renal cell cancer: a shift in approaches for treatment of advanced disease in the United States.

Banegas MP, Harlan LC, Mann B, Yabroff KR.

J Natl Compr Canc Netw. 2014 Sep;12(9):1271-9.

PMID:
25190695
27.

Young and uninsured: Insurance patterns of recently diagnosed adolescent and young adult cancer survivors in the AYA HOPE study.

Parsons HM, Schmidt S, Harlan LC, Kent EE, Lynch CF, Smith AW, Keegan TH; AYA HOPE Collaborative.

Cancer. 2014 Aug 1;120(15):2352-60. doi: 10.1002/cncr.28685. Epub 2014 Jun 4.

28.

Treatment of small cell lung cancer in academic and community settings: factors associated with receiving standard therapy and survival.

Parsons HM, Harlan LC, Stevens JL, Ullmann CD.

Cancer J. 2014 Mar-Apr;20(2):97-104. doi: 10.1097/PPO.0000000000000039.

29.

Treatment of de novo acute myeloid leukemia in the United States: a report from the Patterns of Care program.

Doria-Rose VP, Harlan LC, Stevens J, Little RF.

Leuk Lymphoma. 2014 Nov;55(11):2549-55. doi: 10.3109/10428194.2014.885517. Epub 2014 Mar 7.

PMID:
24467221
30.

Medical care in adolescents and young adult cancer survivors: what are the biggest access-related barriers?

Keegan TH, Tao L, DeRouen MC, Wu XC, Prasad P, Lynch CF, Shnorhavorian M, Zebrack BJ, Chu R, Harlan LC, Smith AW, Parsons HM; AYA HOPE Study Collaborative Group.

J Cancer Surviv. 2014 Jun;8(2):282-92. doi: 10.1007/s11764-013-0332-4. Epub 2014 Jan 10.

31.

Patterns of colorectal cancer care in Europe, Australia, and New Zealand.

Chawla N, Butler EN, Lund J, Warren JL, Harlan LC, Yabroff KR.

J Natl Cancer Inst Monogr. 2013;2013(46):36-61. doi: 10.1093/jncimonographs/lgt009. Review.

32.

Patterns of colorectal cancer care in the United States and Canada: a systematic review.

Butler EN, Chawla N, Lund J, Harlan LC, Warren JL, Yabroff KR.

J Natl Cancer Inst Monogr. 2013;2013(46):13-35. doi: 10.1093/jncimonographs/lgt007. Review.

33.

Talking About Cancer and Meeting Peer Survivors: Social Information Needs of Adolescents and Young Adults Diagnosed with Cancer.

Kent EE, Smith AW, Keegan TH, Lynch CF, Wu XC, Hamilton AS, Kato I, Schwartz SM, Harlan LC.

J Adolesc Young Adult Oncol. 2013 Jun;2(2):44-52.

34.

Multiple myeloma treatment transformed: a population-based study of changes in initial management approaches in the United States.

Warren JL, Harlan LC, Stevens J, Little RF, Abel GA.

J Clin Oncol. 2013 Jun 1;31(16):1984-9. doi: 10.1200/JCO.2012.46.3323. Epub 2013 Apr 8.

35.

Impact of cancer on work and education among adolescent and young adult cancer survivors.

Parsons HM, Harlan LC, Lynch CF, Hamilton AS, Wu XC, Kato I, Schwartz SM, Smith AW, Keel G, Keegan TH.

J Clin Oncol. 2012 Jul 1;30(19):2393-400. doi: 10.1200/JCO.2011.39.6333. Epub 2012 May 21.

36.

Endocrine therapy use among elderly hormone receptor-positive breast cancer patients enrolled in Medicare Part D.

Riley GF, Warren JL, Harlan LC, Blackwell SA.

Medicare Medicaid Res Rev. 2011 Dec 13;1(4). doi: 10.5600/mmrr.001.04.a04.

37.

A population-based study of therapy and survival for patients with head and neck cancer treated in the community.

Dansky Ullmann C, Harlan LC, Shavers VL, Stevens JL.

Cancer. 2012 Sep 15;118(18):4452-61. doi: 10.1002/cncr.27419. Epub 2012 Jan 17.

38.

Identifying specific chemotherapeutic agents in Medicare data: a validation study.

Lund JL, Stürmer T, Harlan LC, Sanoff HK, Sandler RS, Brookhart MA, Warren JL.

Med Care. 2013 May;51(5):e27-34. doi: 10.1097/MLR.0b013e31823ab60f.

39.

Clinical trial participation and time to treatment among adolescents and young adults with cancer: does age at diagnosis or insurance make a difference?

Parsons HM, Harlan LC, Seibel NL, Stevens JL, Keegan TH.

J Clin Oncol. 2011 Oct 20;29(30):4045-53. doi: 10.1200/JCO.2011.36.2954. Epub 2011 Sep 19.

40.

Trends in the treatment and survival for local and regional cutaneous melanoma in a US population-based study.

Harlan LC, Lynch CF, Ballard-Barbash R, Zeruto C.

Melanoma Res. 2011 Dec;21(6):547-54. doi: 10.1097/CMR.0b013e32834b58e4.

41.

Recruitment and follow-up of adolescent and young adult cancer survivors: the AYA HOPE Study.

Harlan LC, Lynch CF, Keegan TH, Hamilton AS, Wu XC, Kato I, West MM, Cress RD, Schwartz SM, Smith AW, Deapen D, Stringer SM, Potosky AL; AYA HOPE Study Collaborative Group.

J Cancer Surviv. 2011 Sep;5(3):305-14. doi: 10.1007/s11764-011-0173-y. Epub 2011 Jan 28.

42.

Ductal carcinoma in situ: trends in treatment over time in the US.

Zujewski JA, Harlan LC, Morrell DM, Stevens JL.

Breast Cancer Res Treat. 2011 May;127(1):251-7. doi: 10.1007/s10549-010-1198-z. Epub 2010 Oct 8.

PMID:
20931276
43.

Population-based estimate of the prevalence of HER-2 positive breast cancer tumors for early stage patients in the US.

Cronin KA, Harlan LC, Dodd KW, Abrams JS, Ballard-Barbash R.

Cancer Invest. 2010 Nov;28(9):963-8. doi: 10.3109/07357907.2010.496759.

44.

Age disparity in the dissemination of imatinib for treating chronic myeloid leukemia.

Wiggins CL, Harlan LC, Nelson HE, Stevens JL, Willman CL, Libby EN, Hromas RA.

Am J Med. 2010 Aug;123(8):764.e1-9. doi: 10.1016/j.amjmed.2010.03.018.

45.

Breast cancer in men in the United States: a population-based study of diagnosis, treatment, and survival.

Harlan LC, Zujewski JA, Goodman MT, Stevens JL.

Cancer. 2010 Aug 1;116(15):3558-68. doi: 10.1002/cncr.25153.

46.

Should cause of death from the death certificate be used to examine cancer-specific survival? A study of patients with distant stage disease.

Lund JL, Harlan LC, Yabroff KR, Warren JL.

Cancer Invest. 2010 Aug;28(7):758-64. doi: 10.3109/07357901003630959.

47.

Feasibility study for collection of HER2 data by National Cancer Institute (NCI) Surveillance, Epidemiology, and End Results (SEER) Program central cancer registries.

Reichman ME, Altekruse S, Li CI, Chen VW, Deapen D, Potts M, Wu XC, Morrell D, Hafterson J, Phipps AI, Harlan LC, Ries LG, Edwards BK.

Cancer Epidemiol Biomarkers Prev. 2010 Jan;19(1):144-7. doi: 10.1158/1055-9965.EPI-09-0807.

48.

Racial/ethnic patterns of care for pancreatic cancer.

Shavers VL, Harlan LC, Jackson M, Robinson J.

J Palliat Med. 2009 Jul;12(7):623-30. doi: 10.1089/jpm.2009.0036.

49.

Comorbidities, therapy, and newly diagnosed conditions for women with early stage breast cancer.

Harlan LC, Klabunde CN, Ambs AH, Gibson T, Bernstein L, McTiernan A, Meeske K, Baumgartner KB, Ballard-Barbash R.

J Cancer Surviv. 2009 Jun;3(2):89-98. doi: 10.1007/s11764-009-0084-3. Epub 2009 May 13.

50.

Patterns of care in a population-based sample of soft tissue sarcoma patients in the United States.

Gadgeel SM, Harlan LC, Zeruto CA, Osswald M, Schwartz AG.

Cancer. 2009 Jun 15;115(12):2744-54. doi: 10.1002/cncr.24307.

Supplemental Content

Loading ...
Support Center